NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 3 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding NovaBridge Biosciences changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 8.99M | 9.40M | +403.0K (+4.5%) |
| Value | $7.41M | $22.7M | +$15.3M (+206.9%) |
New holders (10)
Institutions that held NovaBridge Biosciences at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Candriam Luxembourg S.C.A. | 1,132,563 | $2.74M | 0.02% |
| Ariose Capital Management Ltd | 96,455 | $233.4K | 0.15% |
| Susquehanna International Group, LLP | 37,537 | $90.8K | 0.00% |
| Change Path, LLC | 37,430 | $90.6K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 27,800 | $67.3K | 0.00% |
| Two Sigma Securities, LLC | 12,821 | $31.0K | 0.00% |
| Baxter Bros Inc | 10,000 | $24.2K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1,248 | $3.02K | 0.00% |
| Raymond James Financial Inc | 1,000 | $2.42K | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | $2 | 0.00% |
Sold out (7)
Institutions that held NovaBridge Biosciences at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Stonepine Capital Management, LLC | 483,647 | $398.5K |
| Ground Swell Capital, LLC | 63,730 | $52.5K |
| Millennium Management LLC | 61,478 | $50.7K |
| HBK Sorce Advisory LLC | 46,060 | $37.9K |
| JPMorgan Chase & Co | 5,000 | $4.12K |
| Simplex Trading, LLC | 3,229 | $2.00K |
| Vermillion Wealth Management, Inc. | 200 | $165 |